These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31749889)

  • 1. Aldosterone nongenomically induces angiotensin II receptor dimerization in rat kidney: role of mineralocorticoid receptor and NADPH oxidase.
    Sinphitukkul K; Manotham K; Eiam-Ong S; Eiam-Ong S
    Arch Med Sci; 2019 Oct; 15(6):1589-1598. PubMed ID: 31749889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldosterone nongenomically produces NADPH oxidase-dependent reactive oxygen species and induces myocyte apoptosis.
    Hayashi H; Kobara M; Abe M; Tanaka N; Gouda E; Toba H; Yamada H; Tatsumi T; Nakata T; Matsubara H
    Hypertens Res; 2008 Feb; 31(2):363-75. PubMed ID: 18360057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central interactions of aldosterone and angiotensin II in aldosterone- and angiotensin II-induced hypertension.
    Xue B; Beltz TG; Yu Y; Guo F; Gomez-Sanchez CE; Hay M; Johnson AK
    Am J Physiol Heart Circ Physiol; 2011 Feb; 300(2):H555-64. PubMed ID: 21112947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldosterone Rapidly Enhances Levels of the Striatin and Caveolin-1 Proteins in Rat Kidney: The Role of the Mineralocorticoid Receptor.
    Inthachart K; Manotham K; Eiam-Ong S; Eiam-Ong S
    Endocrinol Metab (Seoul); 2019 Sep; 34(3):291-301. PubMed ID: 31565882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spironolactone suppresses aldosterone-induced Kv1.5 expression by attenuating mineralocorticoid receptor-Nox1/2/4-mediated ROS generation in neonatal rat atrial myocytes.
    Lu G; Li J; Zhai Y; Li Q; Xie D; Zhang J; Xiao Y; Gao X
    Biochem Biophys Res Commun; 2019 Dec; 520(2):379-384. PubMed ID: 31606204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of brain aldosterone and mineralocorticoid receptors in aldosterone-salt hypertension in rats.
    Wang HW; Huang BS; Chen A; Ahmad M; White RA; Leenen FH
    Neuroscience; 2016 Feb; 314():90-105. PubMed ID: 26656220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Rho kinase and oxidative stress in cardiac fibrosis induced by aldosterone and salt in angiotensin type 1a receptor knockout mice.
    Kagiyama S; Matsumura K; Goto K; Otsubo T; Iida M
    Regul Pept; 2010 Feb; 160(1-3):133-9. PubMed ID: 19969025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The involvement of aldosterone in cyclic stretch-mediated activation of NADPH oxidase in vascular smooth muscle cells.
    Ohmine T; Miwa Y; Takahashi-Yanaga F; Morimoto S; Maehara Y; Sasaguri T
    Hypertens Res; 2009 Aug; 32(8):690-9. PubMed ID: 19478813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eplerenone suppresses aldosterone/ salt-induced expression of NOX-4.
    Bayorh MA; Rollins-Hairston A; Adiyiah J; Lyn D; Eatman D
    J Renin Angiotensin Aldosterone Syst; 2011 Sep; 12(3):195-201. PubMed ID: 21292834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid nongenomic action of aldosterone on protein expressions of Hsp90( α and β ) and pc-Src in rat kidney.
    Eiam-Ong S; Sinphitukkul K; Manotham K; Eiam-Ong S
    Biomed Res Int; 2013; 2013():346480. PubMed ID: 23484111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells.
    Miyata K; Rahman M; Shokoji T; Nagai Y; Zhang GX; Sun GP; Kimura S; Yukimura T; Kiyomoto H; Kohno M; Abe Y; Nishiyama A
    J Am Soc Nephrol; 2005 Oct; 16(10):2906-12. PubMed ID: 16135774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative damages in tubular epithelial cells in IgA nephropathy: role of crosstalk between angiotensin II and aldosterone.
    Leung JC; Chan LY; Tang SC; Lam MF; Chow CW; Lim AI; Lai KN
    J Transl Med; 2011 Oct; 9():169. PubMed ID: 21974877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone.
    Keidar S; Kaplan M; Pavlotzky E; Coleman R; Hayek T; Hamoud S; Aviram M
    Circulation; 2004 May; 109(18):2213-20. PubMed ID: 15123520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual blockade of aldosterone and angiotensin II additively suppresses TGF-beta and NADPH oxidase in the hypertensive kidney.
    Onozato ML; Tojo A; Kobayashi N; Goto A; Matsuoka H; Fujita T
    Nephrol Dial Transplant; 2007 May; 22(5):1314-22. PubMed ID: 17324946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mineralocorticoid and angiotensin II type 1 receptors in the subfornical organ mediate angiotensin II - induced hypothalamic reactive oxygen species and hypertension.
    Wang HW; Huang BS; White RA; Chen A; Ahmad M; Leenen FH
    Neuroscience; 2016 Aug; 329():112-21. PubMed ID: 27163380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II triggers apoptosis via enhancement of NADPH oxidase-dependent oxidative stress in a dopaminergic neuronal cell line.
    Zhao HR; Jiang T; Tian YY; Gao Q; Li Z; Pan Y; Wu L; Lu J; Zhang YD
    Neurochem Res; 2015 Apr; 40(4):854-63. PubMed ID: 25666589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [NADPH oxidase-derived reactive oxygen species involved in angiotensin II-induced monocyte chemoattractant protein-1 expression in mesangial cells].
    Chen Y; Zhang AH; Huang SM; Ding GX; Zhang WZ; Bao HY; Wu HM; Chen RH
    Zhonghua Bing Li Xue Za Zhi; 2009 Jul; 38(7):456-61. PubMed ID: 19781192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.
    Stas S; Whaley-Connell A; Habibi J; Appesh L; Hayden MR; Karuparthi PR; Qazi M; Morris EM; Cooper SA; Link CD; Stump C; Hay M; Ferrario C; Sowers JR
    Endocrinology; 2007 Aug; 148(8):3773-80. PubMed ID: 17494996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressing renal NADPH oxidase to treat diabetic nephropathy.
    Tojo A; Asaba K; Onozato ML
    Expert Opin Ther Targets; 2007 Aug; 11(8):1011-8. PubMed ID: 17665974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of apocynin and losartan treatment on renal oxidative stress in a rat model of calcium oxalate nephrolithiasis.
    Li CY; Deng YL; Sun BH
    Int Urol Nephrol; 2009 Dec; 41(4):823-33. PubMed ID: 19241135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.